Immune response modifier post-op

San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.

Related Videos
Related Content

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.